In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...
The community is invited to learn about their brain health during a free month-long webinar series every Thursday to spread ...
Wisconsin's Alzheimer's Association hosted a special Black History Month event Tuesday, addressing Black Americans living with Alzheimer's and other dementia. The event was all about ...
The Alzheimer`s Association Miami Valley Chapter will hold a Zoom later this month on managing caregiver burnout.. The Zoom will take place Feb. 25, from 6:30-7:30 p.m.
Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results